OBJECTIVES: We compared the efficacy of treatments in a rabbit model of coccidioidal meningitis (CM). METHODS: Rabbits were infected intracisternally with Coccidioides immitis and treated with intravenous amphotericin B lipid complex (ABLC), deoxycholate amphotericin B (dAMB), oral fluconazole or diluent [sterile 5% dextrose in water (D5W)]. Survival and cfu in brain, spinal cord and CSF were determined and histology studied. Amphotericin B (AMB) concentrations in serum, CSF and tissue were determined by bioassay. RESULTS: Fluconazole-treated rabbits and controls lost weight and had decreased mobility. All treatments prolonged survival (P = 0.005) and reduced cfu in brain and spinal cord (P <or= 0.008); ABLC or dAMB significantly reduced cfu in CNS tissues compared with fluconazole (all P <or= 0.02). ABLC cleared cfu from CSF faster than dAMB or fluconazole. Histologically, 9/9, 7/8 and 0/24 of the D5W, fluconazole and amphotericin groups, respectively, had severe meningitis. Serum AMB was higher after ABLC at 15 mg/kg than after dAMB (P <or= 0.02). CONCLUSIONS: Intravenous ABLC was efficacious and could be a treatment option for CM.
OBJECTIVES: We compared the efficacy of treatments in a rabbit model of coccidioidal meningitis (CM). METHODS:Rabbits were infected intracisternally with Coccidioides immitis and treated with intravenous amphotericin B lipid complex (ABLC), deoxycholateamphotericin B (dAMB), oral fluconazole or diluent [sterile 5% dextrose in water (D5W)]. Survival and cfu in brain, spinal cord and CSF were determined and histology studied. Amphotericin B (AMB) concentrations in serum, CSF and tissue were determined by bioassay. RESULTS:Fluconazole-treated rabbits and controls lost weight and had decreased mobility. All treatments prolonged survival (P = 0.005) and reduced cfu in brain and spinal cord (P <or= 0.008); ABLC or dAMB significantly reduced cfu in CNS tissues compared with fluconazole (all P <or= 0.02). ABLC cleared cfu from CSF faster than dAMB or fluconazole. Histologically, 9/9, 7/8 and 0/24 of the D5W, fluconazole and amphotericin groups, respectively, had severe meningitis. Serum AMB was higher after ABLC at 15 mg/kg than after dAMB (P <or= 0.02). CONCLUSIONS: Intravenous ABLC was efficacious and could be a treatment option for CM.
Authors: David A Stevens; Yonglong Zhang; Malcolm A Finkelman; Demosthenes Pappagianis; Karl V Clemons; Marife Martinez Journal: J Clin Microbiol Date: 2016-08-24 Impact factor: 5.948
Authors: Karl V Clemons; Javier Capilla; Raymond A Sobel; Marife Martinez; Ann-Jay Tong; David A Stevens Journal: Antimicrob Agents Chemother Date: 2009-03-09 Impact factor: 5.191
Authors: Ashraf S Ibrahim; Teclegiorgis Gebremariam; Mohamed I Husseiny; David A Stevens; Yue Fu; John E Edwards; Brad Spellberg Journal: Antimicrob Agents Chemother Date: 2008-01-28 Impact factor: 5.191
Authors: Aline Raquel Voltan; Guillermo Quindós; Kaila P Medina Alarcón; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini; Marlus Chorilli Journal: Int J Nanomedicine Date: 2016-08-08
Authors: Brenda Kischkel; Suélen A Rossi; Samuel R Santos; Joshua D Nosanchuk; Luiz R Travassos; Carlos P Taborda Journal: Front Cell Infect Microbiol Date: 2020-09-03 Impact factor: 5.293